Skip to main content
Log in

Predictors of the need for pacemaker implantation after the Cox maze IV procedure for atrial fibrillation

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The Cox maze IV (CMIV) procedure is being used increasingly frequently for surgical ablation of atrial fibrillation (AF). This study aimed to identify the risk factors of the need for postoperative pacemaker implantation (PMI) after CMIV.

Methods

Preoperative, intraoperative, and postoperative data were retrospectively collected from 67 consecutive patients who underwent CMIV at our institution; 7 (10.4%) required PMI (as a treatment of brady AF or sick sinus syndrome).

Results

Patients who needed PMI tended to have lower preoperative heart rates than those who did not on a 12-lead electrocardiogram (ECG; 68.7 ± 11.6 vs. 79.1 ± 18.5 bpm, p = 0.07) and a 24-h ECG (94,772 ± 9800 vs. 109,854 ± 19,078 beats/day, p = 0.03). A multivariate analysis identified a low amplitude of the fibrillatory wave on preoperative ECG as a risk factor of PMI necessity after CMIV [odds ratio = 14.7; 95% confidence interval (CI) 1.9–324.7; p = 0.007] and internal use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) as a negative risk factor (odds ratio = 0.16; 95% CI 0.02–0.99; p = 0.049).

Conclusions

A low amplitude of the fibrillatory wave was identified as a risk factor of PMI necessity, whereas the internal use of ACEIs/ARBs diminished the need for PMI. These factors should be considered before CMIV is performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation. Circulation. 2006;114:e257–e354.

    Article  PubMed  Google Scholar 

  2. Nitta T, Ishii Y, Sakamoto S. Surgery for atrial fibrillation: recent progress and future perspective. Gen Thorac Cardiovasc Surg. 2012;60:13–20.

    Article  PubMed  Google Scholar 

  3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–52.

    Article  CAS  PubMed  Google Scholar 

  4. Oi K, Arai H. Stroke associated with coronary artery bypass grafting. Gen Thorac Cardiovasc Surg. 2015;63:487–95.

    Article  PubMed  Google Scholar 

  5. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–5.

    Article  PubMed  Google Scholar 

  6. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–e245.

    Article  PubMed  Google Scholar 

  7. Cox JL, Boineau JP, Schuessler RB, Ferguson TB Jr, Cain ME, Lindsay BD, et al. Successful surgical treatment of atrial fibrillation. Review and clinical update. JAMA. 1991;266:1976–80.

    Article  CAS  PubMed  Google Scholar 

  8. Cox JL, Schuessler RB, D’Agostino HJ Jr, Stone CM, Chang BC, Cain ME, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101:569–83.

    CAS  PubMed  Google Scholar 

  9. Saint LL, Bailey MS, Prasad S, Guthrie TJ, Bell J, Moon MR, et al. Cox-Maze IV results for patients with lone atrial fibrillation vs. concomitant mitral disease. Ann Thorac Surg. 2012;93:789–94.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Takahashi S, Sueda T. Development of the Maze procedure and the contribution of Japanese surgeons. Gen Thorac Cardiovasc Surg. 2017;65:144–52.

    Article  PubMed  Google Scholar 

  11. Gammie JS, Haddad M, Milford-Beland S, Welke KF, Ferguson TB Jr, O’Brien SM, et al. Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg. 2008;85:909–14.

    Article  PubMed  Google Scholar 

  12. Kubota S, Sugiki H, Wakasa S, Ooka T, Tachibana T, Sasaki S, et al. Can we change the operative criteria for the MAZE procedure combined with valve surgery in the era of radiofrequency devices? Gen Thorac Cardiovasc Surg. 2011;59:406–12.

    Article  PubMed  Google Scholar 

  13. Lall SC, Melby SJ, Voeller RK, Zierer A, Bailey MS, Guthrie TJ, et al. The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg. 2007;133:389–96.

    Article  PubMed  Google Scholar 

  14. Ad N, Cox JL. The Maze procedure for the treatment of atrial fibrillation: a minimally invasive approach. J Card Surg. 2004;19:196–200.

    Article  PubMed  Google Scholar 

  15. Robertson JO, Cuculich PS, Saint LL, Schuessler RB, Moon MR, Lawton J, et al. Predictors and risk of pacemaker implantation after the Cox-maze IV procedure. Ann Thorac Surg. 2013;95:2015–20.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Worku B, Pak SW, Cheema F, Russo M, Housman B, Van Patten D, et al. Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation. Ann Thorac Surg. 2011;92:2085–9.

    Article  PubMed  Google Scholar 

  17. Gillinov AM, Bhavani S, Blackstone EH, Rajeswaran J, Svensson LG, Navia JL, et al. Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg. 2006;82:502–13.

    Article  PubMed  Google Scholar 

  18. Shimizu W, Kosakai Y, Inagaki M, Kurita T, Suyama K, Aihara N, et al. Electrophysiologic changes in arrhythmogenic substrate following the maze procedure in patients with lone and paroxysmal atrial fibrillation. Jpn Circ J. 1997;61:988–96.

    Article  CAS  PubMed  Google Scholar 

  19. Kamata J, Kawazoe K, Izumoto H, Kitahara H, Shiina Y, Sato Y, et al. Predictors of sinus rhythm restoration after Cox maze procedure concomitant with other cardiac operations. Ann Thorac Surg. 1997;64:394–8.

    Article  CAS  PubMed  Google Scholar 

  20. Nakamura T, Izutani H, Sawa Y. Mid-term outcomes of the modified Cox-maze procedure for elderly patients: a risk analysis for failure. Interact Cardiovasc Thorac Surg. 2011;12:924–8.

    Article  PubMed  Google Scholar 

  21. Fujita T, Kobayashi J, Toda K, Nakajima H, Iba Y, Shimahara Y, et al. Long-term outcome of combined valve repair and maze procedure for nonrheumatic mitral regurgitation. J Thorac Cardiovasc Surg. 2010;140:1332–7.

    Article  PubMed  Google Scholar 

  22. Xi Q, Sahakian AV, Ng J, Swiryn S. Atrial fibrillatory wave characteristics on surface electrogram: ECG to ECG repeatability over twenty-four hours in clinically stable patients. J Cardiovasc Electrophysiol. 2004;15:911–7.

    Article  PubMed  Google Scholar 

  23. Nault I, Lellouche N, Matsuo S, Knecht S, Wright M, Lim KT, et al. Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation. J Interv Card Electrophysiol. 2009;26:11–9.

    Article  PubMed  Google Scholar 

  24. Nakagawa K, Hirai T, Shinokawa N, Uchiyama Y, Kameyama T, Takashima S, et al. Relation of fibrillatory wave amplitude with hemostatic abnormality and left atrial appendage dysfunction in patients with chronic nonrheumatic atrial fibrillation. Jpn Circ J. 2001;65:375–80.

    Article  CAS  PubMed  Google Scholar 

  25. Thurmann M, Janney JG Jr. The diagnostic importance of fibrillatory wave size. Circulation. 1962;25:991–4.

    Article  CAS  PubMed  Google Scholar 

  26. Morganroth J, Horowitz LN, Josephson ME, Kastor JA. Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. An old generalization re-examined. Am Heart J. 1979;97:184–6.

    Article  CAS  PubMed  Google Scholar 

  27. Lie JT, Falk RH, James TN. Cardiac anatomy and pathologic correlates of atrial fibrillation. In: Falk RH, Podrid PJ, editors. Atrial fibrillation: mechanisms and management. 2nd ed. Philadelphia: Lippincott-Raven; 1997. pp. 23–52.

    Google Scholar 

  28. Atarashi H, Fujiwara T, Saitoh H, Hayakawa H. Age-related decrease in amplitude of f wave in chronic atrial fibrillation (in Japanese). Nihon Ronen Igakkai Zasshi. 1987;24:11–5.

    Article  CAS  PubMed  Google Scholar 

  29. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802–9.

    Article  CAS  PubMed  Google Scholar 

  30. Tan AY, Zhou S, Ogawa M, Song J, Chu M, Li H, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation. 2008;118:916–25.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Xu Y, Sharma D, Li G, Liu Y. Atrial remodeling: new pathophysiological mechanism of atrial fibrillation. Med Hypotheses. 2013;80:53–6.

    Article  PubMed  Google Scholar 

  32. JCS Joint Working Group. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J. 2014;78:1997–2021.

    Article  Google Scholar 

  33. Hirayama Y, Atarashi H, Kobayashi Y, Horie T, Iwasaki Y, Maruyama M, et al. Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J. 2005;69:671–6.

    Article  CAS  PubMed  Google Scholar 

  34. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000;101:2612–7.

    Article  CAS  PubMed  Google Scholar 

  35. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol. 2003;41:2197–204.

    Article  CAS  PubMed  Google Scholar 

  36. Goette A, Arndt M, Röcken C, Spiess A, Staack T, Geller JC, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 2000;101:2678–81.

    Article  CAS  PubMed  Google Scholar 

  37. Dogan A, Akcay S, Karabacak M, Turker Y, Ozaydin M, Erdogan D. The effect of pretreatment with renin-angiotensin-aldosterone system blockers on cardioversion success and acute recurrence of atrial fibrillation. Int J Clin Pract. 2009;63:1017–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshikatsu Saiki.

Ethics declarations

Grants

None.

Conflict of interest

The authors have no potential conflicts of interest to declare in association with this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masaki, N., Kawamoto, S., Motoyoshi, N. et al. Predictors of the need for pacemaker implantation after the Cox maze IV procedure for atrial fibrillation. Surg Today 48, 495–501 (2018). https://doi.org/10.1007/s00595-017-1614-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-017-1614-7

Keywords

Navigation